[2-(5-Methyl-3-phenyl-isoxazol-4-yl)-imidazo[1,2-a]pyridin-7-yl]-carbamic acid tert-butyl ester → 2-(5-Methyl-3-phenyl-isoxazol-4-yl)-imidazo[1,2-a]pyridin-7-ylamine

HRID 731643

Reaktionsgleichung

Reaktionsgleichung von HRID 731643
C(OC(=O)[NH:7][C:8]1[CH:13]=[CH:12][N:11]2[CH:14]=[C:15]([C:17]3[C:18]([C:23]4[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=4)=[N:19][O:20][C:21]=3[CH3:22])[N:16]=[C:10]2[CH:9]=1)(C)(C)C>Cl>[CH3:22][C:21]1[O:20][N:19]=[C:18]([C:23]2[CH:24]=[CH:25][CH:26]=[CH:27][CH:28]=2)[C:17]=1[C:15]1[N:16]=[C:10]2[CH:9]=[C:8]([NH2:7])[CH:13]=[CH:12][N:11]2[CH:14]=1

Komponenten

3

Versuchsvorschrift

A mixture of [2-(5-methyl-3-phenyl-isoxazol-4-yl)-imidazo[1,2-a]pyridin-7-yl]-carbamic acid tert-butyl ester (1.0 g, 2.56 mmol) in hydrochloric acid (4 M in dioxane, 29 mL) was stirred at room temperature for 6 h. The precipitate was then filtered off and dissolved in a dilute solution of sodium hydrogen carbonate and then extracted with ethyl acetate. The organic layer was then washed with brine and then dried over sodium sulphate and evaporated to leave a brown foam. Purification by chromatography (SiO2, heptane:ethyl acetate=100:0 to 25:75) afforded the title compound (477 mg, 64%) which was obtained as a light brown foam. MS: m/e=291.1 [M+H]+.

Aufarbeitung

  1. filtrationThe precipitate was then filtered off
  2. dissolutiondissolved in a dilute solution of sodium hydrogen carbonate
  3. extractionextracted with ethyl acetate
  4. washThe organic layer was then washed with brine
  5. dry with materialdried over sodium sulphate
  6. customevaporated
  7. customto leave a brown foam
  8. customPurification by chromatography (SiO2, heptane:ethyl acetate=100:0 to 25:75)

Quellen und Nachweise

ORD-Eintrag
ord-635211d1d1f6425c87c91612da78fa5f
Quelldatensatz
uspto-grants-2009_09
Patentnummer
US07585874B2

Verknüpfte Notizen

Wird geladen…